• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在现实环境中,皮质类固醇用于新发溃疡性结肠炎患者的缓解诱导治疗。

Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings.

作者信息

Okayasu Motohiro, Ogata Haruhiko, Yoshiyama Yuji

机构信息

Laboratory of Community Pharmacy, Division of Clinical Pharmacy, Research and Education Center for Clinical Pharmacy, School of Pharmacy, Kitasato University, Tokyo, Japan.

Center for Diagnostic and Therapeutic Endoscopy, School of Medicine, Keio University, Tokyo, Japan.

出版信息

J Mark Access Health Policy. 2019 Jan 22;7(1):1565889. doi: 10.1080/20016689.2019.1565889. eCollection 2019.

DOI:10.1080/20016689.2019.1565889
PMID:30719244
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6346708/
Abstract

: Corticosteroids may be temporarily effective for ulcerative colitis (UC), but long-term use increases the risk of adverse drug reactions. : The goal of the study was to examine steroid use in remission induction therapy after diagnosis of UC. : A retrospective observational study using the Japan Medical Data Center (JMDC) Claims Database from January 2008 to December 2014. : Clinics, university hospitals, and national/public hospitals. : Initiation of steroids after diagnosis of UC. : Start time and annual rate of steroid use, and use during the first 6 months of remission induction therapy. : The subjects were 399 patients were newly diagnosed with UC in the study period. The rate of steroid use after diagnosis was 58.4% in 2009, and showed a significant decreasing trend yearly after 2010 (p ≤ 0.0001). Regarding the start time, 52.2% of patients began steroids within 60 days after diagnosis of UC. At 6 months after initiation, 23.7% continued to use steroids and 73.9% of these patients used high-dose steroids. : In treatment of UC after diagnosis, many patients continue to use steroids for >6 months after initiation. Reduced use of steroids based on clinical practice guidelines for UC should be promoted.

摘要

皮质类固醇可能对溃疡性结肠炎(UC)有短期疗效,但长期使用会增加药物不良反应的风险。本研究的目的是调查UC诊断后缓解诱导治疗中类固醇的使用情况。一项回顾性观察研究,使用了日本医疗数据中心(JMDC)2008年1月至2014年12月的索赔数据库。研究机构包括诊所、大学医院和国家/公立医院。观察UC诊断后开始使用类固醇的情况。类固醇使用的开始时间和年使用率,以及缓解诱导治疗前6个月的使用情况。研究期间有399例新诊断为UC的患者。2009年诊断后类固醇的使用率为58.4%,2010年后呈显著下降趋势(p≤0.0001)。关于开始时间,52.2%的患者在UC诊断后60天内开始使用类固醇。开始使用类固醇6个月后,23.7%的患者继续使用,其中73.9%的患者使用高剂量类固醇。在UC诊断后的治疗中,许多患者在开始使用类固醇后持续使用超过6个月。应根据UC临床实践指南促进减少类固醇的使用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/db0a50cc1391/ZJMA_A_1565889_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/394e0ffc5023/ZJMA_A_1565889_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/cb8ddbcec7e1/ZJMA_A_1565889_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/f00a6b9a317f/ZJMA_A_1565889_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/db0a50cc1391/ZJMA_A_1565889_F0004_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/394e0ffc5023/ZJMA_A_1565889_F0001_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/cb8ddbcec7e1/ZJMA_A_1565889_F0002_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/f00a6b9a317f/ZJMA_A_1565889_F0003_OC.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7282/6346708/db0a50cc1391/ZJMA_A_1565889_F0004_OC.jpg

相似文献

1
Use of corticosteroids for remission induction therapy in patients with new-onset ulcerative colitis in real-world settings.在现实环境中,皮质类固醇用于新发溃疡性结肠炎患者的缓解诱导治疗。
J Mark Access Health Policy. 2019 Jan 22;7(1):1565889. doi: 10.1080/20016689.2019.1565889. eCollection 2019.
2
Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.日本溃疡性结肠炎患者的真实世界处方模式和医疗保健费用:一项回顾性理赔数据分析。
Adv Ther. 2021 May;38(5):2229-2247. doi: 10.1007/s12325-020-01615-4. Epub 2021 Jan 30.
3
The incidence of remission and indicators of inadequate response to advanced therapy in patients with ulcerative colitis: results from medical charts in the United Kingdom.溃疡性结肠炎患者接受高级治疗后缓解的发生率和治疗反应不足的指标:来自英国病历的结果。
Curr Med Res Opin. 2023 May;39(5):681-689. doi: 10.1080/03007995.2023.2194782. Epub 2023 Apr 18.
4
Methotrexate for induction of remission in ulcerative colitis.甲氨蝶呤用于诱导溃疡性结肠炎缓解
Cochrane Database Syst Rev. 2014 Aug 27;2014(8):CD006618. doi: 10.1002/14651858.CD006618.pub3.
5
Trends in Corticosteroid Prescriptions for Ulcerative Colitis and Factors Associated with Long-Term Corticosteroid Use: Analysis Using Japanese Claims Data from 2006 to 2016.2006 年至 2016 年日本医保索赔数据分析:溃疡性结肠炎皮质类固醇处方趋势及与长期皮质类固醇使用相关的因素。
J Crohns Colitis. 2021 Mar 5;15(3):358-366. doi: 10.1093/ecco-jcc/jjaa172.
6
Long-Term Benefit of Mesalamine Granules for Patients Who Achieved Corticosteroid-Induced Ulcerative Colitis Remission.美沙拉嗪颗粒对已实现糖皮质激素诱导的溃疡性结肠炎缓解的患者的长期益处。
Dig Dis Sci. 2016 Jan;61(1):221-9. doi: 10.1007/s10620-015-3866-7. Epub 2015 Nov 12.
7
Pulse steroids as induction therapy for children with ulcerative colitis.脉冲式使用类固醇作为溃疡性结肠炎患儿的诱导治疗。
Pediatr Int. 2011 Dec;53(6):974-9. doi: 10.1111/j.1442-200X.2011.03405.x.
8
Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.与溃疡性结肠炎相关的泛发性坏疽性脓皮病:英夫利昔单抗和硫唑嘌呤治疗成功
Acta Dermatovenerol Croat. 2016 Apr;24(1):83-5.
9
Long-interval Cytapheresis as a Novel Therapeutic Strategy Leading to Dosage Reduction and Discontinuation of Steroids in Steroid-dependent Ulcerative Colitis.长期间歇性血细胞分离术作为一种新的治疗策略,可减少类固醇依赖型溃疡性结肠炎患者的类固醇用量并使其停用类固醇。
Intern Med. 2017 Oct 15;56(20):2705-2710. doi: 10.2169/internalmedicine.8428-16. Epub 2017 Sep 15.
10
Azathioprine maintains long-term steroid-free remission through 3 years in patients with steroid-dependent ulcerative colitis.在类固醇依赖型溃疡性结肠炎患者中,硫唑嘌呤可维持长达 3 年的长期无类固醇缓解。
Inflamm Bowel Dis. 2010 Apr;16(4):613-9. doi: 10.1002/ibd.21083.

引用本文的文献

1
Effect of montelukast on remission maintenance in patients with ulcerative colitis: a Randomized, double-blind controlled clinical trial.孟鲁司特对溃疡性结肠炎患者缓解期维持的影响:一项随机、双盲对照临床试验。
BMC Gastroenterol. 2025 Mar 6;25(1):145. doi: 10.1186/s12876-025-03733-1.
2
Change in systemic steroid use and surgery rate in patients with inflammatory bowel disease: a Japanese real-world database analysis.炎症性肠病患者全身类固醇使用和手术率的变化:日本真实世界数据库分析。
J Gastroenterol. 2024 May;59(5):389-401. doi: 10.1007/s00535-024-02086-y. Epub 2024 Mar 16.
3
Association between oral corticosteroid starting dose and the incidence of pneumonia in Japanese patients with ulcerative colitis: a nation-wide claims database study.

本文引用的文献

1
Evidence-based clinical practice guidelines for inflammatory bowel disease.炎症性肠病的循证临床实践指南。
J Gastroenterol. 2018 Mar;53(3):305-353. doi: 10.1007/s00535-018-1439-1. Epub 2018 Feb 10.
2
Defining conditions where long-term glucocorticoid treatment has an acceptably low level of harm to facilitate implementation of existing recommendations: viewpoints from an EULAR task force.定义长期糖皮质激素治疗具有可接受低水平危害的条件,以促进现有建议的实施:来自 EULAR 工作组的观点。
Ann Rheum Dis. 2016 Jun;75(6):952-7. doi: 10.1136/annrheumdis-2015-208916. Epub 2016 Mar 1.
3
NUDT15 R139C causes thiopurine-induced early severe hair loss and leukopenia in Japanese patients with IBD.
日本溃疡性结肠炎患者口服糖皮质激素起始剂量与肺炎发病率之间的关联:一项全国性索赔数据库研究
Intest Res. 2024 Jul;22(3):319-335. doi: 10.5217/ir.2023.00071. Epub 2024 Feb 6.
4
Factors associated with long-term healthcare expense and steroid exposure in patients admitted with acute severe ulcerative colitis.急性重症溃疡性结肠炎患者长期医疗费用及类固醇暴露的相关因素。
JGH Open. 2023 Jul 4;7(7):482-486. doi: 10.1002/jgh3.12933. eCollection 2023 Jul.
5
Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expression.单核细胞来源的髓系抑制细胞的扩增通过 SOCS3 表达改善了辐射引起的肠道炎症反应。
Cell Death Dis. 2021 Sep 3;12(9):826. doi: 10.1038/s41419-021-04103-x.
6
Real-World Prescription Pattern and Healthcare Cost Among Patients with Ulcerative Colitis in Japan: A Retrospective Claims Data Analysis.日本溃疡性结肠炎患者的真实世界处方模式和医疗保健费用:一项回顾性理赔数据分析。
Adv Ther. 2021 May;38(5):2229-2247. doi: 10.1007/s12325-020-01615-4. Epub 2021 Jan 30.
NUDT15 R139C在日本炎症性肠病患者中导致硫嘌呤诱导的早期严重脱发和白细胞减少。
Pharmacogenomics J. 2016 Jun;16(3):280-5. doi: 10.1038/tpj.2015.43. Epub 2015 Jun 16.
4
Prevalence of and outcomes associated with corticosteroid prescription in inflammatory bowel disease.炎症性肠病中皮质类固醇处方的患病率及相关结局
Inflamm Bowel Dis. 2014 Apr;20(4):622-30. doi: 10.1097/MIB.0000000000000008.
5
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2013 update.EULAR 推荐的治疗类风湿关节炎的合成和生物疾病修饰抗风湿药物:2013 更新版。
Ann Rheum Dis. 2014 Mar;73(3):492-509. doi: 10.1136/annrheumdis-2013-204573. Epub 2013 Oct 25.
6
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis.欧洲关于溃疡性结肠炎诊断与管理的第二项循证共识 第1部分:定义与诊断
J Crohns Colitis. 2012 Dec;6(10):965-90. doi: 10.1016/j.crohns.2012.09.003. Epub 2012 Oct 3.
7
Glucocorticosteroid therapy in inflammatory bowel disease: systematic review and meta-analysis.糖皮质激素治疗炎症性肠病:系统评价和荟萃分析。
Am J Gastroenterol. 2011 Apr;106(4):590-9; quiz 600. doi: 10.1038/ajg.2011.70. Epub 2011 Mar 15.
8
Lower doses of 6-mercaptopurine/azathioprine bring enough clinical efficacy and therapeutic concentration of erythrocyte 6-mercaptopurine metabolite in Japanese IBD patients.较低剂量的6-巯基嘌呤/硫唑嘌呤可在日本炎症性肠病患者中带来足够的临床疗效和红细胞6-巯基嘌呤代谢物的治疗浓度。
J Crohns Colitis. 2008 Dec;2(4):315-21. doi: 10.1016/j.crohns.2008.05.002. Epub 2008 Jul 3.
9
Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.成人溃疡性结肠炎实践指南:美国胃肠病学会,实践参数委员会。
Am J Gastroenterol. 2010 Mar;105(3):501-23; quiz 524. doi: 10.1038/ajg.2009.727. Epub 2010 Jan 12.
10
Adverse events of low- to medium-dose oral glucocorticoids in inflammatory diseases: a meta-analysis.低至中等剂量口服糖皮质激素治疗炎症性疾病的不良事件:一项荟萃分析。
Ann Rheum Dis. 2009 Dec;68(12):1833-8. doi: 10.1136/ard.2008.100008. Epub 2008 Dec 9.